Automated Liquid Handling Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

The global automated liquid handling market attained a value of USD 1152.56 Million in 2025 and is projected to expand at a CAGR of 8.60% through 2035. The market is further expected to achieve USD 2630.04 Million by 2035. Rising biologics pipelines, decentralized diagnostics, and persistent laboratory staffing shortages are accelerating adoption of automated liquid handling platforms. These improve output reliability, compliance traceability, and reproducibility across regulated research environments.

Key Market Trends and Insights

• By region, the Asia Pacific automated liquid handling market is expected to record a CAGR of 9.9% over the forecast period.
• The India automated liquid handling industry is expected to grow at a CAGR of 11.4% during the forecast period.
• Biotechnology and pharmaceutical companies are projected to exhibit a CAGR of 9.6% during the forecast period.

Market Size & Forecast

• Market Size in 2025: USD 1152.56 Million
• Projected Market Size in 2035: USD 2630.04 Million
• CAGR from 2026 to 2035: 8.60%
• Fastest-Growing Regional Market: Asia Pacific

The automated liquid handling market growth is largely supported by expanded outsourcing to CROs as well as public investment in life sciences infrastructure. National genomics initiatives and government-backed biobanking programs are paving the way for more automated sample preparation. On the other hand, CROs are harmonizing automation platforms to ensure data consistency across multi-country trials, thus reinforcing the long-term capital equipment standardization.

Pharmaceutical R&D departments are increasingly focusing on automation that could ensure consistent results when the operations span multiple sites, and this is especially evident when non-adherence to the protocol affects regulatory outcomes, driving the automated liquid handling market value. Precision-focused product upgrades and workflow-specific automation strategies are among the ways that leading suppliers of automated liquid handling systems are reshaping the market. In February 2026, Agilent Technologies presented advanced automation, AI-driven workflows, robotic integration, and enhanced imaging solutions at SLAS2026. This move is in line with the increasing pharmaceutical demand for minimizing manual intervention not only in sample preparation but also in assay setup stages.

The continuous changes in the structures of pharmaceutical research, diagnostics, and applied life sciences continue to help the adoption of new technologies to be accelerated. To support cell therapy, next-generation sequencing, and complex screening assays, suppliers are reconstructing liquid handling systems around modular architectures. Companies like Tecan Group are emphasizing the provision of flexible deck configurations and software-controlled workflows thus enabling CROs to increase the number of parallel assays without the need for repeated system validation. In January 2026, Analytik Jena unveiled the PULSEspencer R, a digital, contactless low-volume dispensing system for precise reagent handling and streamlined lab workflows. Simultaneously, equipment manufacturers are developing closer relationships with reagent suppliers for the co-development of automated protocols. This trend in the automated liquid handling market not only allows suppliers to introduce their platforms further into laboratory operations but also raises the switching costs for enterprise buyers.